Filter
335
Filtered Results: 335
Text search:
counterfeit
Featured
Recommendations
18
New Publications
98
Language
Document type
No document type
173
Studies & Reports
78
Guidelines
40
Manuals
16
Strategic & Response Plan
15
Fact sheets
6
Situation Updates
4
Training Material
3
Countries / Regions
Kenya
17
Global
15
Uganda
11
Ethiopia
11
Nigeria
10
Sierra Leone
8
Ghana
7
Liberia
7
Malawi
6
Tanzania
6
India
6
Rwanda
5
Zimbabwe
5
Cambodia
5
South–East Asia Region
5
Western and Central Europe
5
Botswana
5
Myanmar / Burma
5
Bangladesh
4
South Africa
4
Zambia
4
Ukraine
3
Syria
3
Senegal
3
Burkina Faso
3
Philippines
3
Africa
3
Haiti
3
Central African Republic
3
Mali
3
Eswatini/ Swaziland
3
Nepal
2
China
2
Cameroon
2
Latin America and the Carribbean
2
Congo, Democratic Republic of
2
Namibia
2
Indonesia
2
Tajikistan
1
Thailand
1
Lesotho
1
Benin
1
Laos
1
Guinea
1
Mozambique
1
Asia
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
North America
1
Turkmenistan
1
East and Southern Africa
1
Vietnam
1
Moldova
1
Sri Lanka
1
Yemen
1
Somalia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
138
Key Resources
20
Public Health
19
Clinical Guidelines
12
Pharmacy & Technologies
8
Women & Child Health
4
Capacity Building
2
Toolboxes
AMR
44
Pharmacy
39
Mental Health
14
COVID-19
14
Planetary Health
12
Health Financing Toolbox
10
TB
9
HIV
8
Global Health Education
7
Conflict
6
Disability
5
Rapid Response
4
Refugee
3
Ebola & Marburg
3
NTDs
3
Natural Hazards
2
Caregiver
2
NCDs
2
Malaria
2
Specific Hazards
1
Social Ethics
1
Polio
1
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
The Dublin Regulation (Regulation No. 604/2013; sometimes the Dublin III Regulation; previously the Dublin II Regulation and Dublin Convention) is a European Union (EU) law that determines the EU Member State responsible to examine an application for asylum seekers seeking international protection u...
The Department of Nutrition, HIV and AIDS (DNHA) in Ministry of Health and Population is grateful to all stakeholders who contributed to the development of the Nutrition Education Communication Strategy II. The DNHA acknowledges the financial and technical support from the World Bank and USAID throu...
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, policy-makers, planners and others who need to use standardized measurement tools to gather data and other...
In Vietnam, most of the examination and treatment facilities are facing with of spread of bacteria resistant to many antibiotics. The level and speed of drug resistance are increasing, at alarming level. The burden of drug resistance is increasing due to the increasing cost of treatment, prolonged t...
Strategic Advice
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug consumers. These coupled with rapid spread of res...
WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of medicines on behalf of the patients they serve. The role of FIP is to provide leadership for na...
This FY 2018 Malaria Operational Plan (MOP) presents a detailed implementation plan for Ethiopia, based on the strategies of PMI and the National Malaria Control Program (NMCP). It was developed in consultation with the Federal Ministry of Health (FMOH), NMCP, Ethiopian Public Health Institute (EP...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug ...
Public Report
PQMC 0003-003-00 WHO PQMC PR June/2015, version 2.0
The key aim of this guideline is to present recommendations based on a critical evaluation of the evidence on emerging digital health interventions that are contributing to health system improvements, based on an assessment of the benefits, harms, acceptability, feasibility, resource use and equity...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
